Back to mobile site

Regeneron Pharma (REGN) PT Lowered to $855 at Piper Sandler Following Setback

May 18, 2026 7:45 AM EDT Send to a Friend
(Updated - May 18, 2026 9:17 AM EDT)

Piper Sandler analyst Biren Amin lowered the price target on Regeneron ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login